Frequent pathway mutations of splicing machinery in myelodysplasia

Gene set enrichment analysis: A knowledge-based approach for interpreting genome-wide expression profiles

Subramanian, A., Tamayo, P., Mootha, V. K., Mukherjee, S., Ebert, B. L., Gillette, M. A., Paulovich, A., Pomeroy, S. L., Golub, T. R., Lander, E. S., et al. (2005) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0506580102 · Cited by 53,625

Sequencing technologies – the next generation

Metzker, M. L. (2010) · Nature Reviews Genetics · doi:10.1038/nrg2626 · Cited by 7,066

Next-generation DNA sequencing

Shendure, J., & Ji, H. (2008) · Nature Biotechnology · doi:10.1038/nbt1486 · Cited by 4,509

The Spliceosome: Design Principles of a Dynamic RNP Machine

Wahl, M. C., Will, C. L., & Lührmann, R. (2009) · Cell · doi:10.1016/j.cell.2009.02.009 · Cited by 2,665

Recurring mutations found by sequencing an acute myeloid leukemia genome

Mardis, E. R., Ding, L., Dooling, D. J., Larson, D. E., McLellan, M. D., Chen, K., Koboldt, D. C., Fulton, R. S., Delehaunty, K. D., McGrath, S. D., et al. (2009) · New England Journal of Medicine · doi:10.1056/nejmoa0903840 · Cited by 2,219

DNMT3A Mutations in Acute Myeloid Leukemia

Ley, T. J., Ding, L., Walter, M. J., McLellan, M. D., Lamprecht, T., Larson, D. E., Kandoth, C., Payton, J. E., Baty, J., Welch, J., et al. (2010) · New England Journal of Medicine · doi:10.1056/nejmoa1005143 · Cited by 1,983

Somatic mutations altering EZH2 (Tyr641) in follicular and diffuse large B-cell lymphomas of germinal-center origin

Morin, R. D., Johnson, N. A., Severson, T., Mungall, A. J. J., An, J., Goya, R., Paul, J. E., Boyle, M., Woolcock, B. W., Kuchenbauer, F. C., et al. (2010) · Nature Genetics · doi:10.1038/ng.518 · Cited by 1,719

Whole-genome sequencing identifies recurrent mutations in chronic lymphocytic leukaemia

Puente, X. S., Pinyol, M., Quesada, V., Conde, L., Ordóñez, G. R., Villamor, N., Escaramís, G., Jares, P., Beà, S., González, M., et al. (2011) · Nature · doi:10.1038/nature10113 · Cited by 1,529

Initial genome sequencing and analysis of multiple myeloma

Chapman, M. A., Lawrence, M. S., Keats, J. J., Cibulskis, K., Sougnez, C. L., Schinzel, A. C., Harview, C. L., Brunet, J.-P., Ahmann, G. J., Adli, M., et al. (2011) · Nature · doi:10.1038/nature09837 · Cited by 1,457

DNA sequencing of a cytogenetically normal acute myeloid leukaemia genome

Ley, T. J., Mardis, E. R., Ding, L., Fulton, B., McLellan, M. D., Chen, K., Dooling, D. J., Dunford-Shore, B. H., McGrath, S. D., Hickenbotham, M. T., et al. (2008) · Nature · doi:10.1038/nature07485 · Cited by 1,434

Somatic Mutations in Core Spliceosome Components Promote Tumorigenesis and Generate an Exploitable Vulnerability in Human Cancer

Sette, C., & Paronetto, M. P. (2022) · Cancers · doi:10.3390/cancers14071827 · Cited by 30

Targeting splicing factors for cancer therapy

Bashari, A., Siegfried, Z., & Karni, R. (2023) · RNA · doi:10.1261/rna.079585.123 · Cited by 31

SF3B1 mutations in myelodysplastic syndromes: A potential therapeutic target for modulating the entire disease process

Jiang, M., Chen, M., Liu, Q., Jin, Z., Yang, X., & Zhang, W. (2023) · Frontiers in Oncology · doi:10.3389/fonc.2023.1116438 · Cited by 29

METTL3-Mediated m6A Modification Controls Splicing Factor Abundance and Contributes to Aggressive CLL

Wu, Y., Jin, M., Fernandez, M. M., Hart, K. L., Liao, A., Ge, X., Fernandes, S. M., McDonald, T., Chen, Z., Röth, D., et al. (2023) · Blood Cancer Discovery · doi:10.1158/2643-3230.bcd-22-0156 · Cited by 29

Molecular genetics in myelodysplastic syndromes

Haferlach, T. (2012) · Leukemia Research · doi:10.1016/j.leukres.2012.08.009 · Cited by 30

Molecular analyses of 15,542 patients with suspected BCR-ABL1-negative myeloproliferative disorders allow to develop a stepwise diagnostic workflow

Schnittger, S., Bacher, U., Eder, C., Dicker, F., Alpermann, T., Grossmann, V., Kohlmann, A., Kern, W., Haferlach, C., & Haferlach, T. (2012) · Haematologica · doi:10.3324/haematol.2012.064683 · Cited by 29

Cancer-Associated Mutations Mapped on High-Resolution Structures of the U2AF2 RNA Recognition Motifs

Glasser, E., Agrawal, A. A., Jenkins, J. L., & Kielkopf, C. L. (2017) · Biochemistry · doi:10.1021/acs.biochem.7b00551 · Cited by 29

A Loss of Function Screen of Epigenetic Modifiers and Splicing Factors during Early Stage of Cardiac Reprogramming

Zhou, Y., Alimohamadi, S., Wang, L., Liu, Z., Wall, J. B., Yin, C., Liu, J., & Li, Q. (2018) · Stem Cells International · doi:10.1155/2018/3814747 · Cited by 29

Insights into the Involvement of Spliceosomal Mutations in Myelodysplastic Disorders from Analysis of SACY-1/DDX41 in Caenorhabditis elegans

Tsukamoto, T., Gearhart, M. D., Kim, S., Mekonnen, G., Spike, C. A., & Greenstein, D. (2020) · Genetics · doi:10.1534/genetics.119.302973 · Cited by 29

Discoveries, target identifications, and biological applications of natural products that inhibit splicing factor 3B subunit 1

Pham, D., & Koide, K. (2016) · Natural Product Reports · doi:10.1039/c5np00110b · Cited by 28

ETV6 and signaling gene mutations are associated with secondary transformation of myelodysplastic syndromes to chronic myelomonocytic leukemia

Padron, E., Yoder, S., Kunigal, S., Mesa, T., Teer, J. K., Ali, N. E. A., Sekeres, M. A., Painter, J. S., Zhang, L., Lancet, J. E., et al. (2014) · Blood · doi:10.1182/blood-2014-03-562637 · Cited by 28

The phenotypic spectrum of germline YARS2 variants: from isolated sideroblastic anemia to mitochondrial myopathy, lactic acidosis and sideroblastic anemia 2

Riley, L. G., Heeney, M. M., Rudinger‐Thirion, J., Frugier, M., Campagna, D. R., Zhou, R., Hale, G. A., Hilliard, L., Kaplan, J. A., Kwiatkowski, J. L., et al. (2018) · Haematologica · doi:10.3324/haematol.2017.182659 · Cited by 28

NOTCH 1 pathway activating mutations and clonal evolution in pediatric T‐cell acute lymphoblastic leukemia

Kimura, S., Seki, M., Yoshida, K., Shiraishi, Y., Akiyama, M., Koh, K., Imamura, T., Manabe, A., Hayashi, Y., Kobayashi, M., et al. (2018) · Cancer Science · doi:10.1111/cas.13859 · Cited by 28

FBXO11 is a candidate tumor suppressor in the leukemic transformation of myelodysplastic syndrome

Schieber, M., Marinaccio, C., Bolanos, L. C., Haffey, W. D., Greis, K. D., Starczynowski, D. T., & Crispino, J. D. (2020) · Blood Cancer Journal · doi:10.1038/s41408-020-00362-7 · Cited by 28

Amplified EPOR / JAK2 Genes Define a Unique Subtype of Acute Erythroid Leukemia

Takeda, J., Yoshida, K., Nakagawa, M. M., Nannya, Y., Yoda, A., Saiki, R., Ochi, Y., Zhao, L., Okuda, R., Qi, X., et al. (2022) · Blood Cancer Discovery · doi:10.1158/2643-3230.bcd-21-0192 · Cited by 28

Causes and Pathophysiology of Acquired Sideroblastic Anemia

Rodríguez‐Sevilla, J. J., Calvo, X., & Arenillas, L. (2022) · Genes · doi:10.3390/genes13091562 · Cited by 28

Vitamin B5 and succinyl-CoA improve ineffective erythropoiesis in SF3B1 -mutated myelodysplasia

Mian, S. A., Philippe, C., Maniati, E., Protopapa, P., Bergot, T., Piganeau, M., Nemkov, T. G., Bella, D. D., Morales, V., Finch, A. J., et al. (2023) · Science Translational Medicine · doi:10.1126/scitranslmed.abn5135 · Cited by 30

The nexus of long noncoding RNAs, splicing factors, alternative splicing and their modulations

Malakar, P., Shukla, S. K., Mondal, M., Kar, R. K., & Siddiqui, J. A. (2023) · RNA Biology · doi:10.1080/15476286.2023.2286099 · Cited by 28

Tracing the development of acute myeloid leukemia in CBL syndrome

Becker, H., Yoshida, K., Blagitko‐Dorfs, N., Claus, R., Pantić, M., Abdelkarim, M., Niemöller, C., Greil, C., Hackanson, B. W., Shiraishi, Y., et al. (2014) · Blood · doi:10.1182/blood-2013-10-533844 · Cited by 28

Hematopoietic stem cell aging and chronic lymphocytic leukemia pathogenesis

Kikushige, Y., & Miyamoto, T. (2014) · International Journal of Hematology · doi:10.1007/s12185-014-1651-6 · Cited by 29

Interplay between estrogen receptor and AKT in Estradiol-induced alternative splicing

Bhat‐Nakshatri, P., Song, E. K., Collins, N., Uversky, V. N., Dunker, A. K., O’Malley, B. W., Geistlinger, T., Carroll, J. S., Brown, M. A., & Nakshatri, H. (2013) · BMC Medical Genomics · doi:10.1186/1755-8794-6-21 · Cited by 28

Recent advances in the understanding of myelodysplastic syndromes with ring sideroblasts

Malcovati, L., & Cazzola, M. (2016) · British Journal of Haematology · doi:10.1111/bjh.14215 · Cited by 29

Late-Onset Combined Immunodeficiency with a Novel IL2RG Mutation and Probable Revertant Somatic Mosaicism

Okuno, Y., Hoshino, A., Muramatsu, H., Kawashima, N., Wang, X., Yoshida, K., Wada, T., Gunji, M., Toma, T., Kato, T., et al. (2015) · Journal of Clinical Immunology · doi:10.1007/s10875-015-0202-0 · Cited by 28

Acute myeloid leukemia in the era of precision medicine: recent advances in diagnostic classification and risk stratification

Kansal, R., & Kansal, R. (2016) · Cancer Biology and Medicine · doi:10.20892/j.issn.2095-3941.2016.0001 · Cited by 29

Overexpression of RUNX1 short isoform has an important role in the development of myelodysplastic/myeloproliferative neoplasms

Sakurai, H., Harada, Y., Ogata, Y., Kagiyama, Y., Shingai, N., Doki, N., Ohashi, K., Kitamura, T., Komatsu, N., & Harada, H. (2017) · Blood Advances · doi:10.1182/bloodadvances.2016002725 · Cited by 28

Multicenter validation of the flow measurement of classical monocyte fraction for chronic myelomonocytic leukemia diagnosis

Tarfi, S., Harrivel, V., Dumézy, F., Guy, J., Roussel, M., Mimoun, A., Fenaux, P., Chapuis, N., Solary, É., Selimoglu‐Buet, D., et al. (2018) · Blood Cancer Journal · doi:10.1038/s41408-018-0146-8 · Cited by 28

Detection of SRSF2-P95 Mutation by High-Resolution Melting Curve Analysis and Its Effect on Prognosis in Myelodysplastic Syndrome

Lin, J., Yang, J. C., Wen, X., Yang, L., Deng, Z., Qian, Z. Y., Ma, J., Guo, H. Y., Zhang, Y., Qian, W., et al. (2014) · PLoS ONE · doi:10.1371/journal.pone.0115693 · Cited by 27

Mutational profiling in patients with MDS: Ready for every-day use in the clinic?

Bacher, U., Kohlmann, A., & Haferlach, T. (2014) · Best Practice & Research Clinical Haematology · doi:10.1016/j.beha.2014.11.005 · Cited by 27

HapMuC: somatic mutation calling using heterozygous germ line variants near candidate mutations

Usuyama, N., Shiraishi, Y., Sato, Y., Kume, H., Homma, Y., Ogawa, S., Miyano, S., & Imoto, S. (2014) · Bioinformatics · doi:10.1093/bioinformatics/btu537 · Cited by 27

Chronic Myelomonocytic Leukemia: Focus on Clinical Practice

Patnaik, M. M., & Tefferi, A. (2016) · Mayo Clinic Proceedings · doi:10.1016/j.mayocp.2015.11.011 · Cited by 27

Recent advances in the management of therapy-related myelodysplastic syndromes and acute myeloid leukemia

Klimek, V. M. (2013) · Current Opinion in Hematology · doi:10.1097/moh.0b013e32835d82e6 · Cited by 28

Splicing factor mutations in the myelodysplastic syndromes: target genes and therapeutic approaches

Armstrong, R. N., Steeples, V., Singh, S., Sanchi, A., Boultwood, J., & Pellagatti, A. (2017) · Advances in Biological Regulation · doi:10.1016/j.jbior.2017.09.008 · Cited by 30

Chronic myelomonocytic leukemia - a review

Thomopoulos, T. P., Bouhla, A., Papageorgiou, S. G., & Pappa, V. (2020) · Expert Review of Hematology · doi:10.1080/17474086.2021.1860004 · Cited by 27

Phosphorylation regulates arginine-rich RNA-binding protein solubility and oligomerization

Kundinger, S. R., Dammer, E. B., Yin, L., Hurst, C. D., Shapley, S. M., Ping, L., Khoshnevis, S., Ghalei, H., Duong, D. M., & Seyfried, N. T. (2021) · Journal of Biological Chemistry · doi:10.1016/j.jbc.2021.101306 · Cited by 29

Have we reached a molecular era in myelodysplastic syndromes?

Voso, M. T., & Gurnari, C. (2021) · Hematology · doi:10.1182/hematology.2021000276 · Cited by 27

The Biological and Clinical Consequences of RNA Splicing Factor U2AF1 Mutation in Myeloid Malignancies

Zhao, Y., Cai, W., Hua, Y., Yang, X., & Zhou, J. (2022) · Cancers · doi:10.3390/cancers14184406 · Cited by 27

Targeting pre-mRNA splicing in cancers: roles, inhibitors, and therapeutic opportunities

Araki, S., Ohori, M., & Yugami, M. (2023) · Frontiers in Oncology · doi:10.3389/fonc.2023.1152087 · Cited by 30

The role of alternative pre-mRNA splicing in cancer progression

Choi, S., Cho, N., Kim, E.-M., & Kim, K. K. (2023) · Cancer Cell International · doi:10.1186/s12935-023-03094-3 · Cited by 32

Relapse after Allogeneic Hematopoietic Cell Transplantation for Myelodysplastic Syndromes: Analysis of Late Relapse Using Comparative Karyotype and Chromosome Genome Array Testing

Yeung, C. C. S., Gerds, A. T., Fang, M., Scott, B. L., Flowers, M. E. D., Gooley, T. A., & Deeg, H. J. (2015) · Transplantation and Cellular Therapy · doi:10.1016/j.bbmt.2015.04.024 · Cited by 27

Primary Myelodysplastic Syndromes

Gangat, N., Patnaik, M. M., Begna, K. H., Kourelis, T., Al‐Kali, A., Elliott, M. A., Hogan, W. J., Letendre, L., Litzow, M. R., Knudson, R. A., et al. (2015) · Mayo Clinic Proceedings · doi:10.1016/j.mayocp.2015.08.022 · Cited by 27

Next Generation Sequencing in the Clinical Domain: Clinical Advantages, Practical, and Ethical Challenges

Thompson, R., Drew, C. J. G., & Thomas, R. H. (2012) · Advances in protein chemistry and structural biology · doi:10.1016/b978-0-12-394287-6.00002-1 · Cited by 27

Cohesin mutations in myeloid malignancies made simple

Viny, A. D., & Levine, R. L. (2017) · Current Opinion in Hematology · doi:10.1097/moh.0000000000000405 · Cited by 27

Differing clinical features between Japanese and Caucasian patients with myelodysplastic syndromes: Analysis from the International Working Group for Prognosis of MDS

Miyazaki, Y., Tuechler, H., Sanz, G. F., Schanz, J., Garcia‐Manero, G., Solé, F. G., Bennett, J. M., Bowen, D., Fenaux, P., Dreyfus, F., et al. (2018) · Leukemia Research · doi:10.1016/j.leukres.2018.08.022 · Cited by 29

Genetic analysis of a case of Helicobacter pylori-uninfected intramucosal gastric cancer in a family with hereditary diffuse gastric cancer

Funakoshi, T., Miyamoto, S., Kakiuchi, N., Nikaido, M., Setoyama, T., Yokoyama, A., Horimatsu, T., Yamada, A., Torishima, M., Kosugi, S., et al. (2018) · Gastric Cancer · doi:10.1007/s10120-018-00912-w · Cited by 27

Splicing regulatory factors in breast cancer hallmarks and disease progression

Koedoot, E., Wolters, L., van de Water, B., & Dévédec, S. E. L. (2019) · Oncotarget · doi:10.18632/oncotarget.27215 · Cited by 28

Roles of Splicing Factors in Hormone-Related Cancer Progression

Takeiwa, T., Mitobe, Y., Ikeda, K., Horie‐Inoue, K., & Inoue, S. (2020) · International Journal of Molecular Sciences · doi:10.3390/ijms21051551 · Cited by 27

The impact of next generation sequencing technologies on haematological research – A review

Black, J. S., Salto‐Tellez, M., Mills, K., & Catherwood, M. A. (2015) · Pathogenesis · doi:10.1016/j.pathog.2015.05.004 · Cited by 27

ZBP1 senses splicing aberration through Z-RNA to promote cell death

Yang, Z.-H., Wu, P., Zhang, B.-X., Yang, C., Huang, J., Wu, L., Guo, S., Zhou, Y., Mao, Y., Yin, Y., et al. (2025) · Molecular Cell · doi:10.1016/j.molcel.2025.03.023 · Cited by 27

JAK2 inhibitors in the treatment of myeloproliferative neoplasms

Tibes, R., Bogenberger, J. M., Geyer, H. L., & Mesa, R. A. (2012) · Expert Opinion on Investigational Drugs · doi:10.1517/13543784.2012.721352 · Cited by 26

Optimal antisense target reducing INS intron 1 retention is adjacent to a parallel G quadruplex

Královičová, J., Lages, A., Patel, A., Dhir, A., Buratti, E., Searle, M., & Vořechovský, I. (2014) · Nucleic Acids Research · doi:10.1093/nar/gku507 · Cited by 23

Epigenetic modifications in acute myeloid leukemia: The emerging role of circular RNAs (Review)

Issah, M. A., Wu, D., Zhang, F., Zheng, W., Liu, Y., Fu, H., Zhou, H., Chen, R., & Shen, J. (2021) · International Journal of Oncology · doi:10.3892/ijo.2021.5287 · Cited by 26

Congenital sideroblastic anemia model due to ALAS2 mutation is susceptible to ferroptosis

Ono, K., Fujiwara, T., Saito, K., Nishizawa, H., Takahashi, N., Suzuki, C., Ochi, T., Kato, H., Ishii, Y., Onodera, K., et al. (2022) · Scientific Reports · doi:10.1038/s41598-022-12940-9 · Cited by 26

SF3B1 Mutations in Hematological Malignancies

Cilloni, D., Itri, F., Bonuomo, V., & Petiti, J. (2022) · Cancers · doi:10.3390/cancers14194927 · Cited by 26

Prp40 and early events in splice site definition

Becerra, S., Andrés‐León, E., Prieto‐Sánchez, S., Hernández-Munaín, C., & Suñé, C. (2015) · Wiley Interdisciplinary Reviews - RNA · doi:10.1002/wrna.1312 · Cited by 26

Molecular and genetic features of myelodysplastic syndromes

Greenberg, P. L. (2011) · International Journal of Laboratory Hematology · doi:10.1111/j.1751-553x.2011.01390.x · Cited by 27

Trisomy 8, a Cytogenetic Abnormality in Myelodysplastic Syndromes, Is Constitutional or Not?

Saumell, S., Solé, F. G., Arenillas, L., Montoro, M. J., Valcárcel, D., Pedro, C., Sanzo, C., Luño, E., Giménez, T., Arnán, M., et al. (2015) · PLoS ONE · doi:10.1371/journal.pone.0129375 · Cited by 26

MicroRNA deregulation in polycythemia vera and essential thrombocythemia patients

Zhan, H., Cardozo, C. P., Yu, W., Wang, A., Moliterno, A. R., Dang, C. V., & Spivak, J. L. (2012) · Blood Cells Molecules and Diseases · doi:10.1016/j.bcmd.2012.11.009 · Cited by 26

Association of survivin splice variants with prognosis and treatment of breast cancer

Pavlidou, A. (2014) · World Journal of Clinical Oncology · doi:10.5306/wjco.v5.i5.883 · Cited by 26

Establishment and Characterization of Novel Human Primary and Metastatic Anaplastic Thyroid Cancer Cell Lines and Their Genomic Evolution Over a Year as a Primagraft

Garg, M., Okamoto, R., Nagata, Y., Kanojia, D., Venkatesan, S. S., Anand, M. T., Braunstein, G. D., SAID, J. W., Doan, N., Ho, Q. H., et al. (2014) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2014-2359 · Cited by 26

Diagnostic, Prognostic, and Predictive Utility of Recurrent Somatic Mutations in Myeloid Neoplasms

Patel, U., Luthra, R., Medeiros, L. J., & Patel, K. P. (2017) · Clinical Lymphoma Myeloma & Leukemia · doi:10.1016/j.clml.2017.02.015 · Cited by 26

Prognostic value of SRSF2 mutations in patients with de novo myelodysplastic syndromes: A meta-analysis

Zheng, X. Y., Zhan, Z., Naren, D., Li, J., Yan, T., & Gong, Y. (2017) · PLoS ONE · doi:10.1371/journal.pone.0185053 · Cited by 26

Impact of chromosome alterations, genetic mutations and clonal hematopoiesis of indeterminate potential (CHIP) on the classification and risk stratification of MDS

Ganguly, B. B., Banerjee, D., & Agarwal, M. B. (2017) · Blood Cells Molecules and Diseases · doi:10.1016/j.bcmd.2017.10.001 · Cited by 26

Exploiting differential RNA splicing patterns: a potential new group of therapeutic targets in cancer

Jyotsana, N., & Heuser, M. (2017) · Expert Opinion on Therapeutic Targets · doi:10.1080/14728222.2018.1417390 · Cited by 27

Molecular pathophysiology of the myelodysplastic syndromes: insights for targeted therapy

Aleshin, A., & Greenberg, P. L. (2018) · Blood Advances · doi:10.1182/bloodadvances.2018015834 · Cited by 28

Human PRPF40B regulates hundreds of alternative splicing targets and represses a hypoxia expression signature

Lorenzini, P. A., Chew, R. S. E., Tan, C. W., Yong, J. Y., Zhang, F., Zheng, J., & Roca, X. (2019) · RNA · doi:10.1261/rna.069534.118 · Cited by 27

Structures of SF3b1 reveal a dynamic Achilles heel of spliceosome assembly: Implications for cancer-associated abnormalities and drug discovery

Maji, D., Grossfield, A. M., & Kielkopf, C. L. (2019) · Biochimica et Biophysica Acta (BBA) - Gene Regulatory Mechanisms · doi:10.1016/j.bbagrm.2019.194440 · Cited by 27

Innovative Therapeutic and Delivery Approaches Using Nanotechnology to Correct Splicing Defects Underlying Disease

Suñé-Pou, M., Limeres, M. J., Moreno‐Castro, C., Hernández-Munaín, C., Suñé-Negre, J. M., Cuestas, M. L., & Suñé, C. (2020) · Frontiers in Genetics · doi:10.3389/fgene.2020.00731 · Cited by 27

OFCD syndrome and extraembryonic defects are revealed by conditional mutation of the Polycomb-group repressive complex 1.1 (PRC1.1) gene BCOR

Hamline, M. Y., Corcoran, C. M., Wamstad, J. A., Milétich, I., Feng, J., Lohr, J. L., Hemberger, M., Sharpe, P. T., Gearhart, M. D., & Bardwell, V. J. (2020) · Developmental Biology · doi:10.1016/j.ydbio.2020.06.013 · Cited by 26

Next-generation sequencing in hematologic malignancies: what will be the dividends?

Merker, J. D., Valouev, A., & Gotlib, J. R. (2012) · Therapeutic Advances in Hematology · doi:10.1177/2040620712458948 · Cited by 26

A mitochondrial surveillance mechanism activated by SRSF2 mutations in hematologic malignancies

Liu, X., Devadiga, S. A., Stanley, R. F., Morrow, R. M., Janssen, K. A., Quesnel-Vallières, M., Pomp, O., Moverley, A. A., Li, C., Skuli, N., et al. (2024) · Journal of Clinical Investigation · doi:10.1172/jci175619 · Cited by 26

Modulation of aberrant splicing in human RNA diseases by chemical compounds

Kataoka, N. (2017) · Human Genetics · doi:10.1007/s00439-017-1789-4 · Cited by 25

Mutations of RNA splicing factors in hematological malignancies

Shukla, G. C., & Singh, J. (2017) · Cancer Letters · doi:10.1016/j.canlet.2017.08.042 · Cited by 25

SRSF2 Mutations in Uveal Melanoma: A Preference for In-Frame Deletions?

van Poppelen, N. M., Drabarek, W., Smit, K. N., Vaarwater, J., Brands, T., Paridaens, D. A., Kılıç, E., & de Klein, A. (2019) · Cancers · doi:10.3390/cancers11081200 · Cited by 25

Prognosis of MECOM (EVI1)-rearranged MDS and AML patients rather depends on accompanying molecular mutations than on blast count

Summerer, I., Haferlach, C., Meggendorfer, M., Kern, W., Haferlach, T., & Stengel, A. (2020) · Leukemia & lymphoma/Leukemia and lymphoma · doi:10.1080/10428194.2020.1737689 · Cited by 25

Mutations in chronic myelomonocytic leukemia and their prognostic relevance

Jian, J., Qiao, Y., Li, Y. Z., Guo, Y., Ma, H., & Liu, B. (2021) · Clinical & Translational Oncology · doi:10.1007/s12094-021-02585-x · Cited by 25

Aberrant EVI1 splicing contributes to EVI1-rearranged leukemia

Tanaka, A., Nakano, T. A., Nomura, M., Yamazaki, H., Bewersdorf, J. P., Mulet‐Lazaro, R., Hogg, S. J., Liu, B., Penson, A., Yokoyama, A., et al. (2022) · Blood · doi:10.1182/blood.2021015325 · Cited by 25

Retinoid X receptor promotes hematopoietic stem cell fitness and quiescence and preserves hematopoietic homeostasis

Menéndez-Gutierrez, M. P., Porcuna, J., Nayak, R. C., Paredes, A. L., Niu, H., Núñez, V., Paranjpe, A., Gómez, M. J., Bhattacharjee, A., Schnell, D., et al. (2022) · Blood · doi:10.1182/blood.2022016832 · Cited by 29

The detection of SRSF2 mutations in routinely processed bone marrow biopsies is useful in the diagnosis of chronic myelomonocytic leukemia

Federmann, B., Abele, M., Cuesta, D. S. R., Vogel, W., Boiocchi, L., Kanz, L., Quintanilla‐Martínez, L., Orazi, A., Bonzheim, I., & Fend, F. (2014) · Human Pathology · doi:10.1016/j.humpath.2014.08.014 · Cited by 25

The prognostic impact of mutations in spliceosomal genes for myelodysplastic syndrome patients without ring sideroblasts

Kang, M.-G., Kim, H. R., Seo, B.-Y., Lee, J. H., Choi, S., Kim, S., Shin, J. H., Suh, S., Ahn, J., & Shin, M. (2015) · BMC Cancer · doi:10.1186/s12885-015-1493-5 · Cited by 27

BRCC3 mutations in myeloid neoplasms

Huang, D., Nagata, Y., Grossmann, V., Radivoyevitch, T., Okuno, Y., Nagae, G., Hosono, N., Schnittger, S., Sanada, M., Przychodzen, B. P., et al. (2015) · Haematologica · doi:10.3324/haematol.2014.111989 · Cited by 25

Spliceosomal component Sf3b1 is essential for hematopoietic differentiation in zebrafish

Garza, A. D. L., Cameron, R. C., Nik, S., Payne, S. G., & Bowman, T. V. (2016) · Experimental Hematology · doi:10.1016/j.exphem.2016.05.012 · Cited by 26

Dyserythropoiesis of myelodysplastic syndromes

Lefèvre, C., Bondu, S., Goff, S. L., Kosmider, O., & Fontenay, M. (2017) · Current Opinion in Hematology · doi:10.1097/moh.0000000000000325 · Cited by 26

Treatment of myelodysplastic syndrome in the era of next‐generation sequencing

Tobiasson, M., & Kittang, A. O. (2019) · Journal of Internal Medicine · doi:10.1111/joim.12893 · Cited by 26

Myelodysplastic Syndrome-Associated SRSF2 Mutations Cause Splicing Changes by Altering Binding Motif Sequences

Masaki, S., Ikeda, S., Hata, A., Shiozawa, Y., Kon, A., Ogawa, S., Suzuki, K., Hakuno, F., Takahashi, S., & Kataoka, N. (2019) · Frontiers in Genetics · doi:10.3389/fgene.2019.00338 · Cited by 25

Using peripheral blood circulating DNAs to detect CpG global methylation status and genetic mutations in patients with myelodysplastic syndrome

Iriyama, C., Tomita, A., Hoshino, H., Shirahata‐Adachi, M., Furukawa‐Hibi, Y., Yamada, K., Kiyoi, H., & Naoe, T. (2012) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2012.02.071 · Cited by 25

Mutations in RNA Splicing Machinery in Human Cancers

Ebert, B. L., & Bernard, O. (2011) · New England Journal of Medicine · doi:10.1056/nejme1111584 · Cited by 26

The Role of Somatic Mutations in Acute Myeloid Leukemia PathogenesisPreprint

Kishtagari, A., & Levine, R. L. (2020) · Cold Spring Harbor Perspectives in Medicine · doi:10.1101/cshperspect.a034975 · Cited by 26

SF3B1-mutant CMML defines a predominantly dysplastic CMML subtype with a superior acute leukemia-free survival.

Wudhikarn, K., Loghavi, S., Mangaonkar, A. A., Al-Kali, A., Binder, M., Carr, R., Reichard, K., Finke, C., Howard, M., Gangat, N., et al. (2020) · PubMed Central · doi:10.1182/bloodadvances.2020003345 · Cited by 25

Clonal dynamics in a single AML case tracked for 9 years reveals the complexity of leukemia progression

Kim, T., Yoshida, K., Kim, Y. K., Tyndel, M. S., Park, H. J., Choi, S., Ahn, J., Jung, S.-H., Yang, D.-H., Lee, J.-J., et al. (2015) · Leukemia · doi:10.1038/leu.2015.264 · Cited by 24

Pathogenic diversity of RNA variants and RNA variation-associated factors in cancer development

Yang, H. D., & Nam, S. W. (2020) · Experimental & Molecular Medicine · doi:10.1038/s12276-020-0429-6 · Cited by 25

A Comprehensive Overview of Structure‐Activity Relationships of Small‐Molecule Splicing Modulators Targeting SF3B1 as Anticancer Agents

Zhang, D., & Meng, F. (2020) · ChemMedChem · doi:10.1002/cmdc.202000642 · Cited by 24

Ribosome biogenesis is a downstream effector of the oncogenic U2AF1-S34F mutation

Akef, A., McGraw, K. R., Cappell, S. D., & Larson, D. R. (2020) · PLoS Biology · doi:10.1371/journal.pbio.3000920 · Cited by 25

Genetic Aspects of Myelodysplastic/Myeloproliferative Neoplasms

Palomo, L., Acha, P., & Solé, F. G. (2021) · Cancers · doi:10.3390/cancers13092120 · Cited by 24

Genetics of Myelodysplastic Syndromes

Saygin, C., & Godley, L. A. (2021) · Cancers · doi:10.3390/cancers13143380 · Cited by 24

The spectrum of genetic mutations in myelodysplastic syndrome: Should we update prognostication?

Cook, M. R., Karp, J. E., & Lai, C. (2021) · eJHaem · doi:10.1002/jha2.317 · Cited by 26

Insights into established and emerging roles of SR protein family in plants and animals

Kumar, K., Sinha, S. K., Maity, U., Kirti, P. B., & Kumar, K. R. R. (2022) · Wiley Interdisciplinary Reviews - RNA · doi:10.1002/wrna.1763 · Cited by 24

Rare Germline ATM Variants Influence the Development of Chronic Lymphocytic Leukemia

Lampson, B. L., Gupta, A., Tyekucheva, S., Mashima, K., Petráčková, A., Wang, Z., Wojciechowska, N., Shaughnessy, C. J., Baker, P. O., Fernandes, S. M., et al. (2022) · Journal of Clinical Oncology · doi:10.1200/jco.22.00269 · Cited by 24

Discovery of U2AF1 neoantigens in myeloid neoplasms

Biernacki, M. A., Lok, J., Black, R. G., Foster, K. A., Cummings, C. C., Woodward, K. B., Monahan, T. M., Oehler, V. G., Stirewalt, D. L., Wu, D., et al. (2023) · Journal for ImmunoTherapy of Cancer · doi:10.1136/jitc-2023-007490 · Cited by 24

Myelodysplastic syndrome hematopoietic stem cell

Li, J. (2012) · International Journal of Cancer · doi:10.1002/ijc.27896 · Cited by 25

The molecular basis of myeloid malignancies

Kitamura, T., Inoue, D., Okochi, N., Kato, N., Komeno, Y., Yang, L. U., Enomoto, Y., Doki, N., UCHIDA, T., Kagiyama, Y., et al. (2014) · Proceedings of the Japan Academy Series B · doi:10.2183/pjab.90.389 · Cited by 26

Abstract 5119: Frequent splicing pathway mutations and aberrant RNA splicing in myelodysplasia

Yoshida, K., Sanada, M., Shiraishi, Y., Nowak, D., Nagata, Y., Yamamoto, R., Sato, Y., Sato‐Otsubo, A., Kon, A., Nagasaki, M., et al. (2012) · Cancer Research · doi:10.1158/1538-7445.am2012-5119 · Cited by 4

Mutational Spectrum Analysis of Interesting Correlation and Interrelationship Between RNA Splicing Pathway and Commonly Targeted Genes in Myelodysplastic Syndrome

Nagata, Y., Sanada, M., Kon, A., Yoshida, K., Shiraishi, Y., Sato‐Otsubo, A., Mori, H., Ishiyama, K., Sakata‐Yanagimoto, M., Obara, N., et al. (2011) · Blood · doi:10.1182/blood.v118.21.273.273 · Cited by 3

Pathway Mutations in the Splicing Machinery in Myeloid Neoplasms

Ogawa, S. (2012) · Blood · doi:10.1182/blood.v120.21.sci-14.sci-14

Distinct and convergent consequences of splice factor mutations in myelodysplastic syndromes

Madan, V., Li, J., Zhou, S., Teoh, W. W., Han, L., Meggendorfer, M., Malcovati, L., Cazzola, M., Ogawa, S., Haferlach, T., et al. (2019) · American Journal of Hematology · doi:10.1002/ajh.25673 · Cited by 22

Splicing factor mutations in myelodysplasia

Ogawa, S. (2012) · International Journal of Hematology · doi:10.1007/s12185-012-1182-y · Cited by 38